Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies. [electronic resource]
Producer: 20160606Description: 506-15 p. digitalISSN:- 1873-7560
- Aged
- Angiogenesis Inhibitors -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Bone Neoplasms -- drug therapy
- Carcinoma, Renal Cell -- drug therapy
- Databases, Factual
- Diaphragm
- Disease-Free Survival
- Female
- Humans
- Kaplan-Meier Estimate
- Kidney Neoplasms -- drug therapy
- Liver Neoplasms -- drug therapy
- Lymph Nodes -- pathology
- Lymphatic Metastasis
- Male
- Middle Aged
- Neoplasm Metastasis
- Prognosis
- Proportional Hazards Models
- Retroperitoneal Space
- Survival Rate
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.